IFITM Proteins Incorporated into HIV-1 Virions Impair Viral Fusion and Spread.

Archive ouverte

Compton, Alex A | Bruel, Timothée | Porrot, Françoise | Mallet, Adeline | Sachse, Martin | Euvrard, Marine | Liang, Chen | Casartelli, Nicoletta | Schwartz, Olivier

Edité par CCSD ; Elsevier -

International audience. The interferon-induced transmembrane (IFITM) proteins protect cells from diverse virus infections by inhibiting virus-cell fusion. IFITM proteins also inhibit HIV-1 replication through mechanisms only partially understood. We show that when expressed in uninfected lymphocytes, IFITM proteins exert protective effects during cell-free virus infection, but this restriction can be overcome upon HIV-1 cell-to-cell spread. However, when present in virus-producing lymphocytes, IFITM proteins colocalize with viral Env and Gag proteins and incorporate into nascent HIV-1 virions to limit entry into new target cells. IFITM in viral membranes is associated with impaired virion fusion, offering additional and more potent defense against virus spread. Thus, IFITM proteins act additively in both productively infected cells and uninfected target cells to inhibit HIV-1 spread, potentially conferring these proteins with greater breadth and potency against enveloped viruses.

Consulter en ligne

Suggestions

Du même auteur

They Might Be Giants: Does Syncytium Formation Sink or Spread HIV Infection?

Archive ouverte | Schwartz, Olivier | CCSD

International audience

Natural mutations in IFITM 3 modulate post‐translational regulation and toggle antiviral specificity

Archive ouverte | Compton, Alex | CCSD

International audience. The interferon-induced transmembrane (IFITM) proteins protect host cells from diverse virus infections. IFITM proteins also incorporate into HIV-1 virions and inhibit virus fusion and cell-to...

Zika virus induces massive cytoplasmic vacuolization and paraptosis‐like death in infected cells

Archive ouverte | Monel, Blandine | CCSD

International audience. The cytopathic effects of Zika virus (ZIKV) are poorly characterized. Innate immunity controls ZIKV infection and disease in most infected patients through mechanisms that remain to be unders...

Chargement des enrichissements...